We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

News at Geistlich Pharma AG

2021 · 2020 · 2019 · 2018 · 2017 · 2016 · 2015 · 2014 · 2013 ·
  • Complex wounds do not heal easily: This is where our highly refined Advanced Wound Matrix Geistlich Derma-Gide® can provide clinical benefits to those suffering from chronic wounds. The General Services Administration (GSA) in the United States has now included Geistlich Derma-Gide® in the Federal Supply Schedule (FSS) for Veterans Administration medical facilities. With this listing, the product reaches an important milestone, as it is now available to all US veteran hospitals and practices.

  • Prevent tissue loss after immediate implant placement


    Geistlich Bio-Oss® Collagen 50 mg has been developed especially for filling the gap in immediate implant placement. 

  • 325 employees of Geistlich Pharma were involved worldwide in the "Geistlich Charity Walk & Run" for the good cause. Running, walking and hiking they collected 3,988 kilometres, which the company is turning into a donation. The beneficiary of the fundraising campaign and 21,860 US dollars is the Brazilian NGO "Turma do Bem".

  • Due to the current Covid-19 situation, the EAO 2020 planned for Berlin will be transformed into the virtual congress EAO Digital Days. Geistlich is represented with its own symposium as well as with a virtual booth for consultation and exchange. The most important European congress for implantology will take place from 5 to 11 October.

  • The four apprentices at Geistlich Pharma have successfully completed their vocational training with a Swiss Federal Certificate of Competence (EFZ). Geistlich congratulates them warmly. The six new apprentices are in the starting blocks and will begin their training in August.

  • Yesterday, 20 May, the Online Congress Geistlich + YOU took place on the virtual stage with overwhelming popularity. The international event covered the entire spectrum of extraordinary situations and focused in particular on the corona topic in dentistry.

  • Twelve speakers with international appeal are on the starting blocks for Geistlich's first online congress. In addition, over 70 ambitious talents are applying for the novelty of "springboard presentations". The Pioneer Congress is a response by the regeneration specialist Geistlich Pharma to cancelled conventional events and attracts over 6,000 participants to date.

  • Extraordinary situations require extraordinary solutions: In response to cancelled congresses and symposia Geistlich Pharma invites participants to the first online congress on 20 May 2020. Internationally renowned experts and speakers in dentistry have quickly and unbureaucratically pledged their commitment.

  • Given recent events related to Coronavirus and the orders and guidelines issued by the authorities, we have taken measures to protect the health and safety of our employees. Everyone with office duties works from home.

    Despite the challenging circumstances, Geistlich Pharma is currently fully operational, able to deliver and is at your disposal for questions, advice and all your other concerns. We are convinced that we can overcome these...

  • Geistlich Pharma continues its successful business activities and achieves its sales and turnover targets for 2019.

Dr. Mirjam Kessler
Director Corporate Communications